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The aim of this study was to test nectin-4 by immunohistochemistry as a 
potential biomarker in enzootic nasal adenocarcinoma (ENA) of goats. Twenty-
four archival ENA case samples [from 14 male and 10 female hair goats (Capra 
hircus)] were used. The samples were stained with haematoxylin and eosin (HE). 
Nectin-4 expression was studied by immunohistochemistry. By microscopy, tubu-
lar, papillary, and mixed patterns of ENA were diagnosed in the cases. Immuno-
histochemically, the tumours showed moderate nectin-4 expression (++) in 14 
cases (58.3%), strong expression (+++) in five cases (20.8%), and weak expres-
sion (+) in three cases (12.5%), while two cases (8.3%) were negative. Normal 
nasal tissues were not stained with nectin-4. The results suggest that nectin-4 may 
be used as a valuable biomarker of ENA.  
Key words: Goat, nectin-4, enzootic nasal adenocarcinoma, pathology, 
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Enzootic nasal adenocarcinoma (ENA) is a contagious tumour of the nasal 
mucosal glands in sheep and goats. The disease naturally occurs in many coun-
tries around the globe, such as India, Turkey, and Slovenia (Rajan et al., 1980; 
De las Heras et al., 2003; Svara et al., 2006; Ozmen et al., 2010). The clinical 
signs of ENA consist of profuse seromucous nasal exudate, dyspnoea, and 
weight loss (De las Heras et al., 1991; Svara et al., 2006; Ozmen et al., 2010). 
Respiratory diseases of sheep and goats such as parainfluenza, ovine pulmonary 
adenomatosis and various tumour-like nasal polyps (adenopapillomas) should be 
considered in the differential diagnosis of ENA (Chakraborty et al., 2014). His-
tologically, ENA is classified as a low-grade adenocarcinoma according to the 
latest classification system, and its diagnosis is confirmed by histopathological 
examination and immunohistochemical analysis (De las Heras et al., 1998; Svara 
et al., 2006; Ozmen et al., 2010; Aydogan et al., 2013). Enzootic nasal tumour vi-
rus (ENTV) is a simple retrovirus, which causes unilateral or bilateral tumour 
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growth of the mucosal glands in the ethmoidal segment of the nasal cavity (De 
las Heras et al., 1993, 2003).  
Nectin was first described in 1960 (Abrams et al., 1960), and it is required 
for the attachment of the membrane enzyme, ATPase (Baron and Abrams, 1971). 
The nectin family belongs to the Ca2+-independent immunoglobulin-like mole-
cules and is comprised of four members named nectin-1, -2, -3, and -4. This fam-
ily plays a role in cell-cell adhesion that regulates the formation of adherent junc-
tions and tight junctions by epithelial cells in a homophilic and a heterophilic 
manner (Fabre-Lafay et al., 2007; Takai et al., 2008). The cytoplasmic region of 
nectins binds afadin, which directly connects to the actin cytoskeleton (Takai et 
al., 2003). Nectin-4 is a type I transmembrane glycoprotein which has recently 
proven to be overexpressed in human breast carcinoma and is thus considered a 
specific tumour-associated marker, as the normal mammary gland lacks nectin-4 
expression (Fabre-Lafay et al., 2007). In non-small cell lung cancer, a high level 
of nectin-4 expression has been shown to be associated with a poor prognosis 
(Takano et al., 2009). 
In spite of recent studies on nectin-4 expression in cancer, the biological 
and clinical importance of nectin-4 is not fully understood in different types of 
cancer in humans and animals. The aim of the present study was to evaluate 
nectin-4 immunoreactivity as a potential tumour marker in ENA tissues. To the 
best of our knowledge, the expression of nectin-4 has not been studied and re-
ported in ENA so far. 
 
Materials and methods 
Tissue samples 
The material of this study consisted of 24 formalin-fixed, paraffin-
embedded archival ENA case samples [14 male and 10 female hair goats (Capra 
hircus)]. Fixation time in 10% neutral formalin solution did not exceed 48 h. The 
age of the goats was between one and eight years. 
Histopathology and immunohistochemistry 
For histopathological examination, tissue samples were processed rou-
tinely for light microscopy. Five-μm sections were taken from paraffin-
embedded tissues and stained with haematoxylin and eosin (HE). 
Selected ENA sections were stained immunohistochemically in order to 
elucidate the expression of nectin-4 [Millipore, Anti-Nectin-4/PVRL4, clone 
N4.61, Monoclonal Antibody (1:200 dilution)]; cytokeratin AE1/AE3 [Neomarker, 
Keratin, Pan Ab-1, Clone AE1/AE3, Mouse Monoclonal Antibody (1:100 dilu-
tion)]; retrovirus antibody [Retrovirus, Idexx, Maine, USA (ready for use)] using 
a routine streptavidin–biotin–peroxidase technique according to the manufac-
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turer’s recommendations [Abcam, mouse and rabbit specific HRP (ABC) detec-
tion IHC kit (Ab93677)]. The colour reaction was performed with 3,3’- diamino-
benzidine tetrahydrochloride (DAB) substrate kit [Abcam (ab64238)]-H2O2. All 
sections were counterstained with Harris’ haematoxylin, washed in water, and 
cover slips were applied with mounting media. Immunohistochemical reactions 
were controlled to evaluate the specificity of the labels. Haematoxylin and eosin 
staining was performed and used as a reference of tissue cytoarchitecture. On 
each section, different areas were examined and immunopositive reactions were 
demonstrated by the presence of brown cytoplasmic staining. The primary anti-
body was omitted for negative controls. For positive control, human placental 
tissue constitutively expressing nectin-4 was used. Semiquantitative data analysis 
was performed with scores for nectin-4 ranging as ‘–’ for negative staining or 
when none of the cells were stained; ‘+’ for weak staining or when less than 20% 
of the cells were positive; ‘++’ for moderate staining or when 20–59% of the 
cells were positive; and ‘+++’ for strong staining or when more than 60% of the 
cells were positive. 
 
Results 
Clinically and macroscopically, cachexia, dyspnoea, and nasal discharge 
(Fig. 1A) were seen. The tumours located in the ethmoidal area of the nasal cav-
ity were irregular and oval in shape, firm to the touch, polypoid (1 to 3.25 cm in 
length), sessile (0.3–3.5 cm in diameter), and covered with seromucous exudate 
(Fig. 1B). The surface and cut surface of the tumour masses were homogeneous 
or granular, and greyish or pinkish-white in colour. The expansion of tumours in 
the nasal cavity was unilateral in 13 animals and bilateral in 11 animals. No sign 
of secondary sinusitis was seen in the goats. Macroscopic and microscopic ex-
amination did not show metastasis to any organ in any of the cases. 
 
 
Fig. 1A–B. Gross appearance of enzootic nasal adenocarcinoma (ENA). A. Goat with nasal  
discharge (arrow); B. Tumour mass in the nasal cavity (arrows) 
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The histopathological findings were characteristic of ENA and were simi-
lar in all cases examined. Tubular, papillary and mixed structures (Fig. 2A) were 
seen in the cases. Tubular structure was seen in nine cases, papillary structure 
was noted in 10 cases, while mixed structure was observed in five cases. The tu-
mour cells were mostly uniform and cuboidal in shape with round or oval, hy-
perchromatic nuclei. Mitotic figures were uncommon, and the mitotic index was 
2 per 10 high power fields. In seven cases, infiltrations by numerous lympho-
cytes, plasma cells and macrophages were noted in the stroma. In four cases, ar-
eas of coagulation necrosis were observed. There was no histopathological indi-
cation of secondary bacterial infection, vascularisation or intratumoural bleeding. 
Immunohistochemically, normal nasal tissues were not stained with nectin-4. 
In contrast, in the tumours the immunohistochemical results of nectin-4 showed 
that expression was weak (+) in three cases (12.5%) (Fig. 2B), moderate (++) in 
14 cases (58.3%) (Fig. 2C), and strong (+++) in five cases (20.8%) (Fig. 2D); 
there was no expression (–) in two cases (8.3%). Nectin-4 immunoreactions were 
heterogeneous and multifocal in the tumour areas. Positive immunoreactions of 
nectin-4 were seen in the cytoplasm of tumour cells and secretory epithelial cells 
of the ethmoid region. In all cases, cytokeratin AE1/AE3 gave a positive immu-
noreaction in tumour cells and secretory epithelial cells. In addition, retrovirus-
related antigen was expressed in the cytoplasm of tumour cells and on the surface 
of secretory epithelial cells. Marked nectin-4 immunoreactions were more fre-
quently observed in tumours of big size than in small ones. 
Negative immunostaining was seen in the negative control sections con-
firming the specificity of the primary antibodies. 
 
 
Discussion 
Enzootic nasal adenocarcinomas of sheep and goats originate from the 
ethmoid turbinates and show a rising prevalence worldwide (De las Heras et al., 
2003; Fox et al., 2011). This tumour is invasive, mainly of low grade, and it 
rarely forms metastases (De las Heras et al., 1991, 2003). For a suspect case of 
ENA on cytopathology or histopathology, additional diagnostic methods such as 
immunohistochemistry and/or polymerase chain reaction (PCR) are required for 
a precise diagnosis (Stowe et al., 2012). However, different markers have not 
been fully studied immunohistochemically to prove their usefulness for estab-
lishing the precise diagnosis and prognosis of ENA. In this study, nectin-4 ex-
pression was evaluated in nine tubular, 10 papillary and five mixed ENA tissues 
immunohistochemically. In addition, in the cases of this study, the causative 
agent of ENA was demonstrated by retrovirus-related antigen, and the epithelial 
origin of the tumour was immunohistochemically confirmed using an epithelial 
marker named cytokeratin AE1/AE3. 
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Nectins are a newly characterised family of cell adhesion molecules ho-
mologous to PVR/CD155 (the poliovirus receptor) (Lopez et al., 1995; Reymond 
et al., 2001). The nectin family, forming adherent junctions in epithelial cells, 
consists of four members (nectin-1, nectin-2, nectin-3, and nectin-4) (Ikeda et al., 
1999; Takai et al., 2008). Normally, nectins 1, 2 and 3 show abundant expression 
in adult tissues, but nectin-4 is primarily expressed in the embryo and the pla-
centa (Reymond et al., 2001; Fabre-Lafay et al., 2007). Nectin-4 has been shown 
to be a specific tumour-associated marker for ductal mammary carcinoma, lung 
adenocarcinoma and ovarian carcinoma in humans (Fabre-Lafay et al., 2007; Ta-
kano et al., 2009; Derycke et al., 2010). Studies in humans and experimental 
animal models have shown that nectin-4 is a valuable biomarker for evaluating 
tumour progression and the metastatic status of carcinomas (Fabre-Lafay et al., 
2007; Oshima et al., 2013). In this study, we used nectin-4 in ENA, which is a 
type of carcinoma. In spite of a lack of expression of nectin-4 in normal ethmoi-
dal tissues of goats, there was a strong cytoplasmic nectin-4 immunoreaction in 
five cases, a moderate cytoplasmic immunoreaction in 14 cases, and a weak cy-
toplasmic immunoreaction in three cases of ENA. In accordance with previous 
reports in the literature, in this study nectin-4 showed positive immunoreaction in 
a type of carcinoma (ENA) and in adult tissues. However, immunohistochemical 
tests for nectin-4 were negative in the tissues of normal adult goats. This study 
showed that marked nectin-4 reactions were more frequently observed in big-size 
tumours than in small ones. 
In conclusion, this study provides the first results suggesting that nectin-4 
can be used as a valuable biomarker in ENA. These preliminary results have re-
vealed that there is a need for further nectin-4 studies in ENA for establishing the 
diagnosis and prognosis of this tumour, and nectin-4 could also serve as a poten-
tial target for anti-tumour therapy. 
 
References 
Abrams, A., McNamara, P. and Johnson, F. B. (1960): Adenosine triphosphate in isolated bacterial 
cell membranes. J. Biol. Chem. 235, 3659–3662. 
Aydogan, A., Haligur, M. and Ozmen, O. (2013): The expression of caspase-3, caspase-7, caspase-
9 and cytokeratin AE1/AE3 in goats with enzootic nasal adenocarcinoma: an immunohis-
tochemical study. Vet. Med. 58, 417–421. 
Baron, C. and Abrams, A. (1971): Isolation of a bacterial membrane protein, nectin, essential for 
the attachment of adenosine triphosphate. J. Biol. Chem. 246, 1542–1544. 
Chakraborty, S., Kumar, A., Tiwari, R., Rahal, A., Malik, Y., Dhama, K., Pal, A. and Prasad, M. 
(2014): Advances in diagnosis of respiratory diseases of small ruminants. Vet. Med. Inter-
national 6, Special Issue, Article ID 508304, 16 pages. 
De las Heras, M., Garcia de Jalon, J. A. and Sharp, J. M. (1991): Pathology of enzootic intranasal 
tumor in thirty-eight goats. Vet. Pathol. 28, 474–481. 
De las Heras, M., Minguijon, E., Ferrer, L. M., Ortin, A., Dewar, P., Cebrian, L. M., Pascual, Z., 
Garcia, L., Garcia de Jalon, J. A. and Sharp, J. M. (1998): Naturally occurring enzootic nasal 
tumor of sheep in Spain: pathology and associated retrovirus. Eur. J. Vet. Pathol. 4, 11–16. 
 NECTIN-4 EXPRESSION IN ENZOOTIC NASAL ADENOCARCINOMA 77 
Acta Veterinaria Hungarica 64, 2016 
De las Heras, M., Ortin, A., Cousens, C., Minguijón, E. and Sharp, J. M. (2003): Enzootic nasal 
adenocarcinoma of sheep and goats. Curr. Top. Microbiol. Immunol. 275, 201–223. 
De las Heras, M., Sharp, J. M., Ferrer, L. M., Garcia de Jalon, J. A. and Cebrian, L. M. (1993): 
Evidence for a type D-like retrovirus in enzootic nasal tumor of sheep. Vet. Rec. 132, 441. 
Derycke, M. S., Pambuccian, S. E., Gilks, C. B., Kalloger, S. E., Ghidouche, A., Lopez, M., Bliss, 
R. L., Geller, M. A., Argenta, P. A., Harrington, K. M. and Skubitz, A. P. (2010): Nectin 4 
overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker. 
Am. J. Clin. Pathol. 134, 835–845. 
Fabre-Lafay, S., Monville, F., Garrido-Urbani, S., Berruyer-Pouyet, C., Ginestier, C., Reymond, 
N., Finetti, P., Sauvan, R., Adelaide, J., Geneix, J., Lecocq, E., Popovici, C., Dubreuil, P., 
Viens, P., Gonçalves, A., Charafe-Jauffret, E., Janquemier, J., Birnbaum, D. and Lopez, M. 
(2007): Nectin-4 is a new histological and serological tumor associated marker for breast 
cancer. BMC Cancer 7, 73. 
Fox, K. A., Wootton, S. K., Quackenbush, S. L., Wolfe, L. L., Levan, I. K., Miller, M. W. and 
Spraker, T. R. (2011): Paranasal sinus masses of Rocky Mountain bighorn sheep (Ovis 
canadensis canadensis). Vet. Pathol. 48, 706–712. 
Ikeda, W., Nakanishi, H., Miyoshi, J., Mandai, K., Ishizaki, H., Tanaka, M., Togawa, A., Takahashi, 
K., Nishioka, H., Yoshida, H., Mizoguchi, A., Nishikawa, S. and Takai, Y. (1999): Afadin: 
a key molecule essential for structural organization of cell-cell junctions of polarized epi-
thelia during embryogenesis. J. Cell Biol. 146, 1117–1132. 
Lopez, M., Eberle, F., Mattei, M. G., Gabert, J., Birg, F., Bardin, F., Maroc, C. and Dubreuil, P. 
(1995): Complementary DNA characterization and chromosomal localization of a human 
gene related to the poliovirus receptor-encoding gene. Gene 155, 261–265. 
Oshima, T., Sato, S., Kato, J., Ito, Y., Watanabe, T., Tsuji, I., Hori, A., Kurokawa, T. and Kokubo, 
T. (2013): Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers. 
Mol. Cancer 12, 60. 
Ozmen, O., Sahinduran, S., Haligur, M. and Demir, N. (2010): Clinical, pathological, immunohis-
tochemical and ultrastructural observations on enzootic nasal adenocarcinoma in five 
goats. Kafkas Univ. Vet. Fak. Derg. 16, 633–639. 
Rajan, A., Sulochana, S., Sreekumaran, T., Reddi, M. V. and Nair, M. K. (1980): Tumours of the 
ethmoid mucosa in goats (Capra hircus). Indian J. Cancer 17, 196–199. 
Reymond, N., Fabre, S., Lecocq, E., Adelaide, J., Dubreuil, P. and Lopez, M. (2001): Nectin4/ 
PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/ 
PRR1 through V domain interaction. J. Biol. Chem. 276, 43205–43215. 
Stowe, D. M., Anderson, K. L., Guy, J. S., Linder, K. E. and Grindem, C. B. (2012): A case of en-
zootic nasal adenocarcinoma in a ewe. Case Reports in Vet. Med. Article ID 347193, 4 pages. 
Svara, T., Gombac, M., Vrecl, M., Juntes, P., Kostanjsek, R., Pogacnik, A. and Pogacnik, M. 
(2006): Enzootic nasal adenocarcinoma of sheep in Slovenia. J. Vet. Med. A 53, 26–29. 
Takai, Y., Irie, K., Shimizu, K., Sakisaka, K. and Ikeda, W. (2003): Nectins and nectin-like mole-
cules: roles in cell adhesion, migration, and polarization. Cancer Sci. 94, 655–667. 
Takai, Y., Miyoshi, J., Ikeda, W. and Ogita, H. (2008): Nectins and nectin-like molecules: roles in 
contact inhibition of cell movement and proliferation. Nat. Rev. Mol. Cell Biol. 9, 603–615. 
Takano, A., Ishikawa, N., Nishino, R., Masuda, K., Yasui, W., Inai, K., Nishimura, H., Ito, H., Na-
kayama, H., Miyagi, Y., Tsuchiya, E., Kohno, N., Nakamura, Y. and Daigo, Y. (2009): 
Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer. 
Cancer Res. 69, 6694–6703. 
 
 
